Trump’s Trade War Heats Up Again: Drug and Chip Tariffs Could Hit by August 1
Former President Donald Trump has reignited his trade war agenda with a dramatic ultimatum: starting August 1, the US could impose sweeping tariffs on pharmaceutical products and semiconductors, targeting global supply chains and sparking alarm among major US allies and trading partners.
A New Chapter in Trump’s “Reciprocal Tariffs” Strategy
During a press briefing on Tuesday night, Trump revealed that his administration is preparing a “phased tariff rollout” on drug imports, starting with a low tariff to give US-based pharmaceutical manufacturers time—“a year or so”—to re-shore production. But after that grace period? Tariffs could go as high as 200%.
“We’re going to start off with a low tariff and give the pharmaceutical companies a year or so to build,” Trump said. “Then we’re going to make it a very high tariff.”
The same timeline, he added, will apply to semiconductors, a cornerstone of global tech manufacturing, although he called that plan “less complicated” and gave no further specifics.
Pharma and Chips in the Crosshairs
Trump’s new tariff proposals are part of an escalating protectionist campaign aimed at boosting domestic production under the banner of “national security”. The administration is leveraging Section 232 of the Trade Expansion Act of 1962, typically reserved for defense-critical goods, to justify investigations into drug and chip imports.
Pharma Impact: Major Multinationals Under Pressure
If implemented, the pharmaceutical tariffs will likely hit Eli Lilly, Pfizer, and Merck—companies that rely heavily on global production hubs, especially in India, Europe, and East Asia. The tariffs would increase the cost of life-saving medicines and risk inflating drug prices for US consumers, especially in the short term before US capacity ramps up.
Semiconductor Risk: A Blow to Big Tech?
Semiconductors—found in everything from iPhones to tractors—are even more deeply embedded in global supply chains. Tariffs on chips could hit Apple, Samsung, and even US-based fabs like Intel, which depend on both foreign and domestic inputs. Industry insiders warn that such a move may cause ripple effects across consumer electronics, automotive manufacturing, and cloud computing.
Targeting Brazil: A New Front in the Trade War
Coinciding with his tariff threats, Trump also launched a trade investigation into Brazil, citing:
Preferential tariffs
Intellectual property concerns
Digital trade restrictions
Alleged anti-American bias in social media regulation
Ethanol market barriers
Illegal deforestation
The White House described Brazil’s conduct as “unfair”, and the investigation signals a broader clampdown on countries Trump accuses of using trade policies to harm US interests.
Trump last week slapped a 50% tariff on Brazilian imports, accusing the country of conducting a “witch hunt” against its former president Jair Bolsonaro—a close Trump ally. This marks a rare move: imposing tariffs even when the US has a trade surplus with the country in question.
A “Carrot-and-Stick” Deal with Indonesia
Amid these threats, Trump claimed a tariff-reduction deal with Indonesia, cutting the planned 32% tariff down to 19%, after the Southeast Asian nation pledged to:
Purchase 50 Boeing jets
Invest in US agricultural and energy exports
Make multibillion-dollar trade commitments
The deal demonstrates Trump’s transactional diplomacy style: offer big purchases or face steep tariffs.
1 August: The Tariff Clock Is Ticking
The newly announced deadline for the imposition of tariffs—August 1—replaces the earlier July 9 cut-off. The temporary pause was designed to give trade partners time to negotiate, but with only weeks left, global players are scrambling.
The EU’s $4.4 Billion-a-Day Trade in the Balance
The European Union remains in high-stakes negotiations with Washington. Trump has threatened a 30% tariff on all EU imports, prompting fears of a full-blown transatlantic trade war.
EU trade commissioner Maroš Šefčovič warned that such tariffs would “eliminate” trade between the US and EU, which currently totals €4.4 billion per day. He remains hopeful that a “negotiated solution” can be found before the August deadline.
Will There Be Retaliation?
Despite predictions of tit-for-tat responses, only China and Canada have so far pledged retaliatory tariffs. Other nations appear to be adopting a wait-and-see approach, possibly betting that Trump won’t follow through—what some in trade circles call the “TACO effect” (“Trump Always Chickens Out”).
Still, with the US Treasury reporting $64 billion in customs revenue from April to June—$47 billion more than the same period last year—Trump’s strategy is, from a fiscal standpoint, working in the short term.
Winners and Losers in Trump’s Trade Blitz
Winners:
US-based manufacturers in pharmaceuticals and semiconductors—if they can scale up fast
Customs revenue collectors, who’ve seen record surpluses
Trump’s base, which favors domestic production and tough stances against globalization
Losers:
Multinationals with global supply chains in drugs, tech, and heavy metals
US consumers, who may face higher prices for medicine, electronics, and vehicles
Emerging markets like Brazil and Bangladesh, who rely on US trade access
What’s Next?
If past behavior is any indication, Trump may continue using tariff threats as leverage in negotiation. But if 200% drug tariffs and 50% chip levies become reality, the implications for global health, technology, and economic stability could be profound.
With the August 1 deadline looming, stakeholders across sectors—from pharma and electronics to agriculture and clean energy—are watching nervously. Whether this is brinkmanship or policy reality will be revealed soon.
Tariff Brinkmanship as Trade Doctrine
Trump’s aggressive reactivation of tariffs reflects a broader ideological commitment: weaponizing trade to bring manufacturing home. Whether it succeeds or backfires will depend on the willingness of allies to retaliate—or capitulate—and how fast US industry can fill the void.
